108 related articles for article (PubMed ID: 34446004)
21. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
Hou J; Yao C
Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215
[TBL] [Abstract][Full Text] [Related]
22. Identification of lung adenocarcinoma specific dysregulated genes with diagnostic and prognostic value across 27 TCGA cancer types.
Shang J; Song Q; Yang Z; Li D; Chen W; Luo L; Wang Y; Yang J; Li S
Oncotarget; 2017 Oct; 8(50):87292-87306. PubMed ID: 29152081
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
24. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.
Lu L; Liu LP; Zhao QQ; Gui R; Zhao QY
Front Oncol; 2021; 11():675545. PubMed ID: 34249715
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
Ma B; Geng Y; Meng F; Yan G; Song F
J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375
[No Abstract] [Full Text] [Related]
27. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
29. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
Wu C; Rao X; Lin W
Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
Wang Y; Deng H; Xin S; Zhang K; Shi R; Bao X
Front Genet; 2019; 10():349. PubMed ID: 31105737
[No Abstract] [Full Text] [Related]
31. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
[TBL] [Abstract][Full Text] [Related]
33. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
Wang Y; Chen W; Zhu M; Xian L
Front Mol Biosci; 2021; 8():692530. PubMed ID: 34395526
[No Abstract] [Full Text] [Related]
34. Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
Zhu P; Gu S; Huang H; Zhong C; Liu Z; Zhang X; Wang W; Xie S; Wu K; Lu T; Zhou Y
Oncol Lett; 2021 Jun; 21(6):488. PubMed ID: 33968204
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma.
Wu G; Wang Q; Zhu T; Fu L; Li Z; Wu Y; Zhang C
Front Genet; 2021; 12():681277. PubMed ID: 34306024
[TBL] [Abstract][Full Text] [Related]
36. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
37. Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma.
Ye J; Liu H; Xu ZL; Zheng L; Liu RY
J Clin Lab Anal; 2019 Nov; 33(9):e22990. PubMed ID: 31402485
[TBL] [Abstract][Full Text] [Related]
38. A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis.
Xiong Y; Lei J; Zhao J; Lu Q; Feng Y; Qiao T; Xin S; Han Y; Jiang T
BMC Cancer; 2020 Oct; 20(1):1046. PubMed ID: 33129284
[TBL] [Abstract][Full Text] [Related]
39. A five-long non-coding RNA signature with the ability to predict overall survival of patients with lung adenocarcinoma.
Zeng L; Wang W; Chen Y; Lv X; Yuan J; Sun R; Yang S
Exp Ther Med; 2019 Dec; 18(6):4852-4864. PubMed ID: 31777562
[TBL] [Abstract][Full Text] [Related]
40. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
